Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How we hear distance: Echoes are essential for humans to perceive how far away a sound is

  • Presence of heart pouch may explain strokes of unknown origin, study finds

  • Researchers 'smell' new receptors that could underlie the many actions of the anesthetic drug ketamine

  • Phone counseling reduces pain, disability after back surgery

  • Antioxidant therapy may have promising potential in concussion treatment

  • Alcohol-related cues, stress strongly impact females and increase 'craving'-like behavior

  • Migrating immune cells promote nerve cell demise in the brain

  • Electroconvulsive therapy changes key areas of the human brain that play a role in memory, emotion

  • Neurological diseases share common blood-brain barrier defects

  • Study of brain networks shows differences in children with OCD

  •